Clinical trial
Early Proctologic Effects of GLP-1 Receptor Agonist Therapy in Morbidly Obese Patients: A Prospective Cohort Study With Baseline and 3-Month Proctologic Assessment
NCT07668765 is registered in ClinicalTrials.gov with Gazi University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Proctologic Effects of GLP-1 Receptor Agonist Therapy in Morbidly Obese Patients: A Prospective Cohort Study With Baseline and 3-Month Proctologic Assessment
- Lead sponsor
- Gazi University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- August 31, 2026
- Completion date
- May 31, 2027
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anorectal diseases, constipation, diarrhea, drug-related side effects and adverse reactions, morbid obesity